News
Worldwide, at least seven people have been "cured" of HIV—or at least have had long-term sustained remission. This means that ...
Scientific research has gifted us with a range of evidence-based options to protect ourselves from getting infected with HIV.
HIV treatment stops the HIV replication that causes immune damage. But there are places in the body where the virus "hides" ...
The US Food and Drug Administration (FDA) has approved lenacapavir, an injectable drug that offers long-lasting protection ...
Lenacapavir has demonstrated enormous potential as a new HIV prevention tool with a 100 per cent efficacy rate and zero ...
Lenacapavir, the injectable drug developed by a US-based company, Gilead Sciences, was trialled (tested) in Uganda and South ...
HealthLink talked with a Seattle-based physician about why the newly approved drug could be a game-changer in preventing HIV.
Jeremy Gregson was sitting in his Northwest Indiana home two years ago when he got the call that his blood work from earlier ...
Cambodia has launched a long-acting injectable HIV prevention drug, Cabotegravir for Pre-Exposure Prophylaxis (CAB-PrEP), ...
An injection that can prevent HIV infection for six months has been approved by the US Food and Drug Administration (FDA).
Gilead's lenacapavir approval by the US Food and Drug Administration (FDA) marks a milestone in HIV prevention, but experts warn over its expense. Sophie Cousins reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results